OBIO launches Women in Health Initiative
July 13, 2022
TORONTO – The Ontario Bioscience Innovation Organization, a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is excited to announce the expansion of Canada’s Early Adopter Health Network (EAHN) and the launch of its new Women in Health Initiative (WiHI) to train women to further ensure their participation and career success in the health science industry.
Both initiatives are supported by the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) as part of a new $10-million investment in OBIO.
The announcement builds on an additional $10 million in FedDev Ontario support, provided to OBIO since 2015, to assist high-potential health and life sciences companies to grow, scale up and attract global investment.
Maura Campbell (pictured), president and CEO of OBIO, is thrilled with the continued growth of OBIO’s programs and other initiatives. “We are delighted to expand EAHN and provide Canadian health technology companies with an opportunity to partner with healthcare organizations.
EAHN was developed to evaluate and facilitate the adoption of cutting-edge technologies that improve patients’ lives while providing solutions to healthcare system challenges. We are also very proud to highlight that through WiHI, OBIO’s latest initiative, we will work to ensure the career success of participating women in the health science industry by drawing on our in-house training expertise and extensive network of professionals, advisors and companies.”
EAHN brings together health technology companies and healthcare organizations in a collaborative health system to evaluate, refine, adopt and procure Canadian-made technology solutions. This new funding will be leveraged to grow and expand the network by creating opportunities for companies and healthcare organizations across the entire healthcare ecosystem, from tertiary care and community hospitals to primary care, long-term care organizations and homecare.